Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06787729 · ClinicalTrials.gov registry record · NA

At Home Wearable Sensors and Smartphone for Stroke Survivors With Upper Limb Motor Challenges.

A NA study of Stroke, sponsored by Spaulding Rehabilitation Hospital.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06787729: Recruiting NA study of Stroke, sponsored by Spaulding Rehabilitation Hospital.

NCT06787729 is a NA study of Stroke that is actively recruiting participants, run by Spaulding Rehabilitation Hospital. The registered enrollment target is 50 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06787729, a NA study of Stroke, is actively recruiting participants, sponsored by Spaulding Rehabilitation Hospital.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to learn if wearable sensor data visualization on smartphones can improve the use of the stroke-affected limb during everyday activities. Chronic stroke survivors (\>12 months from onset) ages 18-80 years old with residual upper extremity motor impairments may be eligible to participate. The main question it aims to answer is: Does the mobile health (mHealth) intervention help to improve the use of the stroke-affected upper-limb during daily living? The study is designed so each participant serves as their own control. Researchers will compare information from the baseline, intervention, and retention time periods to see if visualizing the data on the smartphone impacts the participant's daily use of the arm. Participants will be asked to wear a set of wearable ring and wrist sensors and interact with a custom-designed smartphone app, aiming to increase the use of their stroke-affected limb during daily activities as much as possible. They will receive feedback from the app, communicate with study therapists, participate in goal setting, complete clinical assessments, and share about their experience using the system during a virtual interview.

Primary Outcome

This outcome measure assesses upper extremity function and use through patient report. Items are scored using a 6-point ordinal scale. For the Amount Scale, 0=the weaker arm was not used at all for that activity (not used), while 5=the weaker arm was used as often as before the stroke (same as pre-stroke). The score is calculated by adding the rating scores for each item and dividing by the number of items asked.

Conditions Studied

Interventions

  • DEVICE mHealth

Study Locations (1)

Massachusetts

  • Spaulding Rehabilitation Hospital, Motion Analysis Laboratory - Charlestown

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-10
Est. Completion 2026-07
Phase NA
Spaulding Rehabilitation Hospital

101 total trials

What NCT06787729 shows while recruiting

NCT06787729 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which mHealth is the first listed.

NCT06787729 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06787729 about?

NCT06787729 is a clinical study titled "At Home Wearable Sensors and Smartphone for Stroke Survivors With Upper Limb Motor Challenges.". The goal of this clinical trial is to learn if wearable sensor data visualization on smartphones can improve the use of the stroke-affected limb during everyday activities. Chronic stroke survivors (\>12 months from onset) ages 18-80 years old with residual upper extremity motor impairments may be e...

What is the current status of trial NCT06787729?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-10. Estimated completion is 2026-07.

What conditions does trial NCT06787729 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT06787729?

The interventions under investigation include: mHealth (DEVICE).

Who is sponsoring clinical trial NCT06787729?

This trial is sponsored by Spaulding Rehabilitation Hospital, which has 101 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06787729 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06787729's enrollment target sits among peer trials

50 232nd of 454 higher than 209 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT06787729, the US trial registry maintained by the National Library of Medicine. NCT06787729 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.